ABC Co entered the industry of Research and Development Laboratories in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code , which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact Hassibullah Akeefe by calling (925) 209-1081 during business hours. You can also write to the business’ Single Location at 3521 Investment Blvd # 1, Hayward, California CA 94545. You can also visit the company’s website at tm3therapeutics.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | ABC Co |
| Representative: | Hassibullah Akeefe |
| Place of Business: | 3521 Investment Blvd # 1, Hayward, CA 94545 |
| Contact Number: | (925) 209-1081 |
| Website: | tm3therapeutics.com |
| Type of Service: | Research and Development Laboratories |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2008 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
ABC Co is a company operating from Alameda, California providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2008 and registered with the SIC code as Research and Development Laboratories, and with the NAICS code as Research and Development Laboratories.
With a current employee count of 1 to 4, ABC Co has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Hassibullah Akeefe at (925) 209-1081 for related queries, or to locate its Single Location using the coordinates 37.62573,-122.11982.
The Single Location can also be found at the street address 3521 Investment Blvd # 1 in Hayward, California 94545 and can be engaged online through the company website at tm3therapeutics.com, the company Twitter , and Facebook page .